Imaging Technology

JUNE 27, 2023

Urbain, MD, PhD, FASNC , professor of radiology/nuclear medicine and medicine, vice chair of theranostics, and director of nuclear medicine at Roswell Park Cancer Center at the University of Buffalo , Buffalo, New York. and ‘How can we ensure diversity in all parts of the nuclear medicine family?’

Nuclear Medicine 115

Nuclear Medicine Imaging Hospital Radiology 115

AuntMinnie

MARCH 26, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

AuntMinnie

JUNE 20, 2024

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. Lutathera was approved for adults by the FDA in 2018 after the therapy resulted in progression-free survival (median overall survival of 11.7

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

Imaging Technology

MAY 31, 2023

“We can’t treat what we don’t see, which is why we require precise image quality to help diagnose, plan treatment for, and monitor disease,” explains Prof. Flavio Forrer , MD, PhD, Chairman of Nuclear Medicine in the Division of Radiology and Nuclear Medicine at Kantonsspital St. Gallen in Switzerland [vii].

Nuclear Medicine 98

Nuclear Medicine Healthcare Healthcare IT 98

Imaging Technology

JUNE 29, 2023

by the Company and a collaborator at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, June 24 – 27, 2023. program in prostate cancer with the nuclear medicine community at the SNMMI 2023 Annual Meeting,” said David E. 177Lu-rhPSMA-10.1 Gauden , D.Phil., and 177Lu-PSMA I&T.

Clinic 98

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 98

Imaging Technology

APRIL 3, 2023

These capabilities will help them develop and deliver products with the potential to improve care for even more patients with serious disease. “In Mr. Merrick concluded, “This is a very exciting and dynamic time for NorthStar and all those involved in nuclear medicine.

Medical 98

Medical Radiopharmaceuticals Pharmaceutical Radiation 98